Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2004 / Cilt: 30 - Sayı: 1

The early effects of flexible colonoscopy and rectoscopy on serum total free and free/total prostate specific antigen levels

Kolonoskopi ve rektoskopinin erken dönemde serum total serbest ve serbest/total prostat spesifik antijen değerleri üzerine etkileri

Pages
86–90
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We believe that to avoid false interpretation, total and free PSA measurements should precede these procedures if they have to be obtained on the same day.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Manipulations of the prostate gland that may cause rupture of the basement membrane have the potential of causing elevated PSA levels.
📊
Key Findings & Data:After the raised question of whether the transrectal manipulation of a large colonoscope for more than 30 minutes may affect serum PSA levels, Schwartz et al. in their previously reported study in which PSA measurements 24 hours, 7 days and 30 days after colonoscopy were compared with the PSA levels 24-72 hours before the procedure, have stated that colonoscopy has no adverse effect on serum total PSA levels.
💡
Conclusion & Impact:We believe that to avoid false interpretation, total and free PSA measurements should precede these procedures if they have to be obtained on the same day.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Prostata özgü antijen · İleriye dönük çalışma · Prostat neoplazmları

Abstract

Introduction: Manipulations of the prostate gland that may cause rupture of the basement membrane have the potential of causing elevated PSA levels. After the raised question of whether the transrectal manipulation of a large colonoscope for more than 30 minutes may affect serum PSA levels, Schwartz et al. in their previously reported study in which PSA measurements 24 hours, 7 days and 30 days after colonoscopy were compared with the PSA levels 24-72 hours before the procedure, have stated that colonoscopy has no adverse effect on serum total PSA levels. To examine the issue further, we conducted the present prospective study on the diurnal early effects of colonoscopy and a shorter procedure rectoscopy, on serum total, free and free/total prostate specific antigen (PSA) levels. Materials and Methods: Forty-seven consecutive men in whom flexible colonoscopy or rectoscopy was to be performed enrolled in the study. Twenty-eight of the patients undervvent colonoscopy and 19 patients underwent rectoscopy. Serum total and free PSA levels were measured immediately before and 2 hours after the procedures. The signifıcance of differences between total, free and free/total PSA values obtained before and after the procedures, any possible correlation with procedure time ör age with PSA increases was analyzed by the paired t test. Results: Statistically signifıcant increases vvere observed between pre-examination and post-examination total and free PSA values after colonoscopy and rectoscopy (p<0.001). Duration of the procedure and age had no Statistically signifıcant effect on total or free PSA values (p>0.05). Serum total PSA increases vvere encountered in 89% of the patients in the colonoscopy group and 95% in the rectoscopy group. in the colonoscopy group, total PSA increased from 0.89+0.73 ng/mL to 2.54±1.88 ng/mL (p=0.001). in the rectoscopy group, total PSA increased from 0.96±0.58 to 2.87+1.74 ng/mL. in 17 patients (37%), the post-procedure total PSA value was above 4 ng/mL. in 14 (50%) of the patients who underwent colonoscopy and in 11 (57%) of the patients who underwent rectoscopy, the increase vvas more than 0.75 ng/mL. Free to total PSA ratio values decreased under the level of 20% in 30% of the patients. Conclusion: Short period after the procedures, colonoscopy and rectoscopy cause signifıcant increases in total and free PSA values and decreases in free/total PSA ratios without any correlation with age or procedure time. We believe that to avoid false interpretation, total and free PSA measurements should precede these procedures if they have to be obtained on the same day.

Özet

Kolonoskopi ve rektoskopinin serum total, serbest ve serbest/total prostat spesifik antijen (PSA) seviyeleri üzerine olan etkilerinin araştırıldığı prospektif bir çalışma yürütüldü. Kolonoskopi yapılan 28 hasta ve rektoskopi yapılan 19 hasta olmak üzere toplam 47 olgu çalışma kapsamına alındı. İşlem öncesi ve işlemden 2 saat sonra alman kan örneklerinde total ve serbest PSA değerlerine bakıldı, işlem öncesi ve sonrasında elde edilen bulgular arasında istatistiksel olarak anlamlı bir değişikliğin olup olmadığı ve yaş veya işlem süresinin bu değişikliklerle olan ilişkisi Paired t testi ile araştırıldı.Hem kolonoskopi hem de rektoskopi sonrasında istatistiksel olarak anlamlı şekilde total ve serbest PSA'da artış saptandı (p 0.05). Kolonoskopi sonrasında %89, rektoskopi sonrasında %94 hastada total PSA değerlerinde artış olmuştur. Bu artış 17 (%37) hastada 4 ng/mL'nin üzerindedir. PSA, kolonoskopi yapılan hastaların 14'ünde (%50) ve rektoskopi yapılan hastaların 11'inde (%57) yıllık artış hızı olan 0.75 ng/mL'nin üzerine çıkmıştır. Hastaların %30'unda serbest/total PSA oranı %20'nin altında saptanmıştır. Kolonoskopi ve rektoskopi erken dönemde yaş ve işlem süresinden bağımsız olarak total ve serbest PSA değerlerinde yükselmeye, serbest/total PSA oranında düşmeye neden olmaktadır.

🔖

Cite This Article

EĞİLMEZ, M. T., GÜMÜRDÜLÜ, Y., GÜVEL, S., KILINÇ, F., YAYCIOĞLU, Ö., ÖZKARDEŞ, H. (2004). The early effects of flexible colonoscopy and rectoscopy on serum total free and free/total prostate specific antigen levels. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 30 - Sayı: 1, 86–90. https://ajindex.com/articles/328478

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Oesterling JE: Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol. 145: 907, 1991
  2. Chan DW, Bruzek DJ, Oesterling JE, et al: Prostate-specific antigen as a marker for prostatic cancer: A monoclonal and a polyclonal immunassay compared. Clin Chem. 33: 1916, 1987
  3. Catalona WJ, Smith DS, Rattliff DL, et al: Measurement of prostate specific antigen in serum as a screening test for prostate cancer. New Eng J Med. 324: 1156-1161, 1991
  4. Crawford ED, DeAntoni EP, Etzieri R, et al: Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. Urology. 47: 863-869, 1996
  5. Mettlin C, Jones G, Averette H, et al: Defining and updating the American Cancer Society guidelines for the cancer related check-up of prostate and endometrial cancers. Ca Cancer J. Clin. 43: 42-46, 1993
  6. Oesterling JE, Jacobsen SJ, Chute CG, et al: Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA. 270: 860, 1993
  7. Tchetgen MB, Oesterling JE: The effect of prostatitis, urinary retention, ejaculation and ambulation on the serum prostate-specific antigen concentration. Urol Clin North Am. 24(2): 323-332, 1997
  8. Oesterling JE, Rice DC, Glenski WJ, et al: Ef-fects of cystoscopy, prostate biopsy and transu-rethral resection of prostate on serum prostate-specific antigen concentration. Urology. 42: 276, 1993
  9. Juan JJ, Coplen DE, Petros JA, et al: Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. J Urol. 147: 810-814, 1992
  10. Byers T, Levin B, Rothenberger D, et al: American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update. American Cancer Society detection and treatment advisory group on colorectal cancer. Cancer J Phys. 47: 154-160, 1997
  11. Schwartz BF, Faught J, Jezior JR: The effect of colonoscopy on serum prostate specific antigen levels. BJU International. 84: 302-304, 1999
  12. Stamey TA, Yang N, Hay AR, et al: Prostate-specific antigen as a serum marker for adenocar-cinoma of the prostate. N Engl J Med. 317: 909, 1987
  13. Krumholtz JS, Carvalhal GF, Ramos CG, et al: Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features.